239 related articles for article (PubMed ID: 31382906)
1. De novo truncating variant in NSD2gene leading to atypical Wolf-Hirschhorn syndrome phenotype.
Jiang Y; Sun H; Lin Q; Wang Z; Wang G; Wang J; Jiang F; Yao R
BMC Med Genet; 2019 Aug; 20(1):134. PubMed ID: 31382906
[TBL] [Abstract][Full Text] [Related]
2. From Wolf-Hirschhorn syndrome to NSD2 haploinsufficiency: a shifting paradigm through the description of a new case and a review of the literature.
Wiel LC; Bruno I; Barbi E; Sirchia F
Ital J Pediatr; 2022 May; 48(1):72. PubMed ID: 35550183
[TBL] [Abstract][Full Text] [Related]
3. The first familial NSD2 cases with a novel variant in a Chinese father and daughter with atypical WHS facial features and a 7.5-year follow-up of growth hormone therapy.
Hu X; Wu D; Li Y; Wei L; Li X; Qin M; Li H; Li M; Chen S; Gong C; Shen Y
BMC Med Genomics; 2020 Dec; 13(1):181. PubMed ID: 33276791
[TBL] [Abstract][Full Text] [Related]
4. Developmental delay and failure to thrive associated with a loss-of-function variant in WHSC1 (NSD2).
Boczek NJ; Lahner CA; Nguyen TM; Ferber MJ; Hasadsri L; Thorland EC; Niu Z; Gavrilova RH
Am J Med Genet A; 2018 Dec; 176(12):2798-2802. PubMed ID: 30345613
[TBL] [Abstract][Full Text] [Related]
5. De novo loss-of-function variants in
Barrie ES; Alfaro MP; Pfau RB; Goff MJ; McBride KL; Manickam K; Zmuda EJ
Cold Spring Harb Mol Case Stud; 2019 Aug; 5(4):. PubMed ID: 31171569
[TBL] [Abstract][Full Text] [Related]
6. De novo truncating variants in WHSC1 recapitulate the Wolf-Hirschhorn (4p16.3 microdeletion) syndrome phenotype.
Derar N; Al-Hassnan ZN; Al-Owain M; Monies D; Abouelhoda M; Meyer BF; Moghrabi N; Alkuraya FS
Genet Med; 2019 Jan; 21(1):185-188. PubMed ID: 29892088
[TBL] [Abstract][Full Text] [Related]
7. 109 kb deletion of chromosome 4p16.3 in a patient with mild phenotype of Wolf-Hirschhorn syndrome.
Okamoto N; Ohmachi K; Shimada S; Shimojima K; Yamamoto T
Am J Med Genet A; 2013 Jun; 161A(6):1465-9. PubMed ID: 23637096
[TBL] [Abstract][Full Text] [Related]
8. De novo nonsense mutation in WHSC1 (NSD2) in patient with intellectual disability and dysmorphic features.
Lozier ER; Konovalov FA; Kanivets IV; Pyankov DV; Koshkin PA; Baleva LS; Sipyagina AE; Yakusheva EN; Kuchina AE; Korostelev SA
J Hum Genet; 2018 Jul; 63(8):919-922. PubMed ID: 29760529
[TBL] [Abstract][Full Text] [Related]
9. Case report: A
Yang Q; Gong D; Yi S; Luo J; Zhang Q
Front Pediatr; 2023; 11():1064783. PubMed ID: 37351323
[TBL] [Abstract][Full Text] [Related]
10. The constitutional gain-of-function variant p.Glu1099Lys in NSD2 is associated with a novel syndrome.
Popp B; Brugger M; Poschmann S; Bartolomaeus T; Radtke M; Hentschel J; Di Donato N; Rump A; Gburek-Augustat J; Graf E; Wagner M; Sorge I; Lemke JR; Meitinger T; Abou Jamra R; Strehlow V; Brunet T
Clin Genet; 2023 Feb; 103(2):226-230. PubMed ID: 36189577
[TBL] [Abstract][Full Text] [Related]
11. Deletions involving genes WHSC1 and LETM1 may be necessary, but are not sufficient to cause Wolf-Hirschhorn Syndrome.
Andersen EF; Carey JC; Earl DL; Corzo D; Suttie M; Hammond P; South ST
Eur J Hum Genet; 2014 Apr; 22(4):464-70. PubMed ID: 23963300
[TBL] [Abstract][Full Text] [Related]
12. Wolf-Hirschhorn syndrome facial dysmorphic features in a patient with a terminal 4p16.3 deletion telomeric to the WHSCR and WHSCR 2 regions.
Engbers H; van der Smagt JJ; van 't Slot R; Vermeesch JR; Hochstenbach R; Poot M
Eur J Hum Genet; 2009 Jan; 17(1):129-32. PubMed ID: 18830230
[TBL] [Abstract][Full Text] [Related]
13. Submicroscopic duplication of the Wolf-Hirschhorn critical region with a 4p terminal deletion.
Roselló M; Monfort S; Orellana C; Ferrer-Bolufer I; Quiroga R; Oltra S; Martínez F
Cytogenet Genome Res; 2009; 125(2):103-8. PubMed ID: 19729912
[TBL] [Abstract][Full Text] [Related]
14. Loss-of-function and missense variants in NSD2 cause decreased methylation activity and are associated with a distinct developmental phenotype.
Zanoni P; Steindl K; Sengupta D; Joset P; Bahr A; Sticht H; Lang-Muritano M; van Ravenswaaij-Arts CMA; Shinawi M; Andrews M; Attie-Bitach T; Maystadt I; Belnap N; Benoit V; Delplancq G; de Vries BBA; Grotto S; Lacombe D; Larson A; Mourmans J; Õunap K; Petrilli G; Pfundt R; Ramsey K; Blok LS; Tsatsaris V; Vitobello A; Faivre L; Wheeler PG; Wevers MR; Wojcik M; Zweier M; Gozani O; Rauch A
Genet Med; 2021 Aug; 23(8):1474-1483. PubMed ID: 33941880
[TBL] [Abstract][Full Text] [Related]
15. A microdeletion proximal of the critical deletion region is associated with mild Wolf-Hirschhorn syndrome.
Hannes F; Hammond P; Quarrell O; Fryns JP; Devriendt K; Vermeesch JR
Am J Med Genet A; 2012 May; 158A(5):996-1004. PubMed ID: 22438245
[TBL] [Abstract][Full Text] [Related]
16. On the nosology and pathogenesis of Wolf-Hirschhorn syndrome: genotype-phenotype correlation analysis of 80 patients and literature review.
Zollino M; Murdolo M; Marangi G; Pecile V; Galasso C; Mazzanti L; Neri G
Am J Med Genet C Semin Med Genet; 2008 Nov; 148C(4):257-69. PubMed ID: 18932124
[TBL] [Abstract][Full Text] [Related]
17. Interstitial microdeletion of 4p16.3: contribution of WHSC1 haploinsufficiency to the pathogenesis of developmental delay in Wolf-Hirschhorn syndrome.
Izumi K; Okuno H; Maeyama K; Sato S; Yamamoto T; Torii C; Kosaki R; Takahashi T; Kosaki K
Am J Med Genet A; 2010 Apr; 152A(4):1028-32. PubMed ID: 20358621
[No Abstract] [Full Text] [Related]
18. 4p16.1-p15.31 duplication and 4p terminal deletion in a 3-years old Chinese girl: Array-CGH, genotype-phenotype and neurological characterization.
Piccione M; Salzano E; Vecchio D; Ferrara D; Malacarne M; Pierluigi M; Ferrara I; Corsello G
Eur J Paediatr Neurol; 2015 Jul; 19(4):477-83. PubMed ID: 25769226
[TBL] [Abstract][Full Text] [Related]
19. Clinical and epilepsy characteristics in Wolf-Hirschhorn syndrome (4p-): A review.
Paprocka J; Kaminiów K; Yetkin O; Tekturk P; Baykan B; Leiz S; Kluger G; Striano P
Seizure; 2024 Mar; 116():14-23. PubMed ID: 36526544
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
